Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-03-23 09:14 CET (UTC+1h)
 

Bayesian BE Assessment [Study As­sess­ment]

posted by DavidManteigas - Portugal, 2017-03-14 11:45  - Posting: # 17153
Views: 127

Hi Ben,

If current frequentist methods for studies where bayesian analysis may fit (two-stage) are full of controversies in the regulators point of view, I can't even imagine if you introduce bayesian methods to them in those cases :-D

I'm not a frequentist phanatic. I believe both approaches are valid depending on the problems and study designs under consideration. Regarding bioequivalence however, I don't see how bayesian inference may add any value. The same is not true for therapeutic equivalence studies (biosimilars), where I believe bayesian methods would be very advantageous since you already "have" prior "information" regarding treatments.

Regards,
David

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
16,685 Posts in 3,582 Threads, 1,009 registered users;
18 users online (0 registered, 18 guests).

Anyone who has never made a mistake
has never tried anything new.    Albert Einstein

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed